AstraZeneca says updated COVID vaccine report still shows it's highly effective
CBSN
AstraZeneca insisted late Wednesday that its COVID-19 vaccine is strongly effective even after including additional illnesses in its disputed U.S. study, the latest in an extraordinary public rift with American officials.
In a late-night press release, the British drug maker said it had recalculated data from that advanced trial and concluded the vaccine is 76% effective in preventing symptomatic COVID-19, instead of the 79% it had claimed earlier in the week. Just a day earlier, an independent panel that oversees the study had accused AstraZeneca of cherry-picking data to tout the protection offered by its vaccine. The panel, in a harsh letter to the company and to U.S. health leaders, said the company had left out some COVID-19 cases that occurred in the study, a move that could erode trust in the science.
Gold Coast, Australia — The Iranian women's soccer team left Australia minus seven of its members who were granted asylum, after tearful protests of their departure at Sydney Airport and frantic final efforts inside the terminal by Australian officials who sought to ensure the women understood they were being offered asylum. In:

The White House is aware that Gulf countries have said they're running short on missile interceptors, and that they've said they're having to choose which objects to blow up — and which not to — multiple sources told CBS News. The White House has discussed the matter, the sources said. Margaret Brennan contributed to this report. In:











